▶ 調査レポート

アルテスネート薬の世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Artesunate Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。アルテスネート薬の世界市場 2020年:企業別、地域別、種類・用途別 / Global Artesunate Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0804-15230資料のイメージです。• レポートコード:D0804-15230
• 出版社/出版日:GlobalInfoResearch / 2020年7月
• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医薬品・治療
• 販売価格(消費税別)
  Single User¥361,920 (USD3,480)▷ お問い合わせ
  Multi User¥542,880 (USD5,220)▷ お問い合わせ
  Corporate User¥723,840 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、アルテスネート薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。アルテスネート薬の種類別市場規模(単芳香族アルテスナート、複合アルテスナート)、用途別市場規模(病院、クリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Fosun Pharma (Guilin)、MCW Healthcare、Ajanta Pharma、Ipca Laboratories、Acino、Sanofi Aventis、Cipla、Shin Poong
・地域別グローバル市場分析 2015年-2020年
・アルテスネート薬の北米市場(アメリカ、カナダ、メキシコ)
・アルテスネート薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・アルテスネート薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・アルテスネート薬の南米市場(ブラジル、アルゼンチン)
・アルテスネート薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:単芳香族アルテスナート、複合アルテスナート
・用途別分析:病院、クリニック、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Artesunate Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Artesunate Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Artesunate Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Artesunate Drugs market has been segmented into:
Monoaromatic Artesunate
Compound Artesunate

By Application, Artesunate Drugs has been segmented into:
Hospital
Clinic
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Artesunate Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Artesunate Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Artesunate Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Artesunate Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Artesunate Drugs Market Share Analysis
Artesunate Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Artesunate Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Artesunate Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Artesunate Drugs are:
Fosun Pharma (Guilin)
MCW Healthcare
Ajanta Pharma
Ipca Laboratories
Acino
Sanofi Aventis
Cipla
Shin Poong

レポート目次

Table of Contents

1 Artesunate Drugs Market Overview
1.1 Product Overview and Scope of Artesunate Drugs
1.2 Classification of Artesunate Drugs by Type
1.2.1 Global Artesunate Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Artesunate Drugs Revenue Market Share by Type in 2019
1.2.3 Monoaromatic Artesunate
1.2.4 Compound Artesunate
1.3 Global Artesunate Drugs Market by Application
1.3.1 Overview: Global Artesunate Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Artesunate Drugs Market by Regions
1.4.1 Global Artesunate Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Artesunate Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Artesunate Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Artesunate Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Artesunate Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Artesunate Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Artesunate Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Fosun Pharma (Guilin)
2.1.1 Fosun Pharma (Guilin) Details
2.1.2 Fosun Pharma (Guilin) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Fosun Pharma (Guilin) SWOT Analysis
2.1.4 Fosun Pharma (Guilin) Product and Services
2.1.5 Fosun Pharma (Guilin) Artesunate Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 MCW Healthcare
2.2.1 MCW Healthcare Details
2.2.2 MCW Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 MCW Healthcare SWOT Analysis
2.2.4 MCW Healthcare Product and Services
2.2.5 MCW Healthcare Artesunate Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ajanta Pharma
2.3.1 Ajanta Pharma Details
2.3.2 Ajanta Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ajanta Pharma SWOT Analysis
2.3.4 Ajanta Pharma Product and Services
2.3.5 Ajanta Pharma Artesunate Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ipca Laboratories
2.4.1 Ipca Laboratories Details
2.4.2 Ipca Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Ipca Laboratories SWOT Analysis
2.4.4 Ipca Laboratories Product and Services
2.4.5 Ipca Laboratories Artesunate Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Acino
2.5.1 Acino Details
2.5.2 Acino Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Acino SWOT Analysis
2.5.4 Acino Product and Services
2.5.5 Acino Artesunate Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi Aventis
2.6.1 Sanofi Aventis Details
2.6.2 Sanofi Aventis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi Aventis SWOT Analysis
2.6.4 Sanofi Aventis Product and Services
2.6.5 Sanofi Aventis Artesunate Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cipla SWOT Analysis
2.7.4 Cipla Product and Services
2.7.5 Cipla Artesunate Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Shin Poong
2.8.1 Shin Poong Details
2.8.2 Shin Poong Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Shin Poong SWOT Analysis
2.8.4 Shin Poong Product and Services
2.8.5 Shin Poong Artesunate Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Artesunate Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Artesunate Drugs Players Market Share
3.2.2 Top 10 Artesunate Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Artesunate Drugs Revenue and Market Share by Regions
4.2 North America Artesunate Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Artesunate Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Artesunate Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Artesunate Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Artesunate Drugs Revenue and Growth Rate (2015-2020)
5 North America Artesunate Drugs Revenue by Countries
5.1 North America Artesunate Drugs Revenue by Countries (2015-2020)
5.2 USA Artesunate Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Artesunate Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Artesunate Drugs Revenue and Growth Rate (2015-2020)
6 Europe Artesunate Drugs Revenue by Countries
6.1 Europe Artesunate Drugs Revenue by Countries (2015-2020)
6.2 Germany Artesunate Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Artesunate Drugs Revenue and Growth Rate (2015-2020)
6.4 France Artesunate Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Artesunate Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Artesunate Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Artesunate Drugs Revenue by Countries
7.1 Asia-Pacific Artesunate Drugs Revenue by Countries (2015-2020)
7.2 China Artesunate Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Artesunate Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Artesunate Drugs Revenue and Growth Rate (2015-2020)
7.5 India Artesunate Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Artesunate Drugs Revenue and Growth Rate (2015-2020)
8 South America Artesunate Drugs Revenue by Countries
8.1 South America Artesunate Drugs Revenue by Countries (2015-2020)
8.2 Brazil Artesunate Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Artesunate Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Artesunate Drugs by Countries
9.1 Middle East & Africa Artesunate Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Artesunate Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Artesunate Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Artesunate Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Artesunate Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Artesunate Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Artesunate Drugs Market Forecast by Type (2019-2024)
10.3 Monoaromatic Artesunate Revenue Growth Rate (2015-2025)
10.4 Compound Artesunate Revenue Growth Rate (2015-2025)
11 Global Artesunate Drugs Market Segment by Application
11.1 Global Artesunate Drugs Revenue Market Share by Application (2015-2020)
11.2 Artesunate Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Artesunate Drugs Market Size Forecast (2021-2025)
12.1 Global Artesunate Drugs Market Size Forecast (2021-2025)
12.2 Global Artesunate Drugs Market Forecast by Regions (2021-2025)
12.3 North America Artesunate Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Artesunate Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Artesunate Drugs Revenue Market Forecast (2021-2025)
12.6 South America Artesunate Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Artesunate Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Artesunate Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Artesunate Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Artesunate Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Artesunate Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Fosun Pharma (Guilin) Corporate Information, Location and Competitors
Table 6. Fosun Pharma (Guilin) Artesunate Drugs Major Business
Table 7. Fosun Pharma (Guilin) Artesunate Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Fosun Pharma (Guilin) SWOT Analysis
Table 9. Fosun Pharma (Guilin) Artesunate Drugs Product and Solutions
Table 10. Fosun Pharma (Guilin) Artesunate Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. MCW Healthcare Corporate Information, Location and Competitors
Table 12. MCW Healthcare Artesunate Drugs Major Business
Table 13. MCW Healthcare Artesunate Drugs Total Revenue (USD Million) (2018-2019)
Table 14. MCW Healthcare SWOT Analysis
Table 15. MCW Healthcare Artesunate Drugs Product and Solutions
Table 16. MCW Healthcare Artesunate Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Ajanta Pharma Corporate Information, Location and Competitors
Table 18. Ajanta Pharma Artesunate Drugs Major Business
Table 19. Ajanta Pharma Artesunate Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Ajanta Pharma SWOT Analysis
Table 21. Ajanta Pharma Artesunate Drugs Product and Solutions
Table 22. Ajanta Pharma Artesunate Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Ipca Laboratories Corporate Information, Location and Competitors
Table 24. Ipca Laboratories Artesunate Drugs Major Business
Table 25. Ipca Laboratories Artesunate Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Ipca Laboratories SWOT Analysis
Table 27. Ipca Laboratories Artesunate Drugs Product and Solutions
Table 28. Ipca Laboratories Artesunate Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Acino Corporate Information, Location and Competitors
Table 30. Acino Artesunate Drugs Major Business
Table 31. Acino Artesunate Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Acino SWOT Analysis
Table 33. Acino Artesunate Drugs Product and Solutions
Table 34. Acino Artesunate Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sanofi Aventis Corporate Information, Location and Competitors
Table 36. Sanofi Aventis Artesunate Drugs Major Business
Table 37. Sanofi Aventis Artesunate Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Sanofi Aventis SWOT Analysis
Table 39. Sanofi Aventis Artesunate Drugs Product and Solutions
Table 40. Sanofi Aventis Artesunate Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Cipla Corporate Information, Location and Competitors
Table 42. Cipla Artesunate Drugs Major Business
Table 43. Cipla Artesunate Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Cipla SWOT Analysis
Table 45. Cipla Artesunate Drugs Product and Solutions
Table 46. Cipla Artesunate Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Shin Poong Corporate Information, Location and Competitors
Table 48. Shin Poong Artesunate Drugs Major Business
Table 49. Shin Poong Artesunate Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Shin Poong SWOT Analysis
Table 51. Shin Poong Artesunate Drugs Product and Solutions
Table 52. Shin Poong Artesunate Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Artesunate Drugs Revenue (Million USD) by Players (2015-2020)
Table 54. Global Artesunate Drugs Revenue Share by Players (2015-2020)
Table 55. Global Artesunate Drugs Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Artesunate Drugs Revenue Market Share by Regions (2015-2020)
Table 57. North America Artesunate Drugs Revenue by Countries (2015-2020)
Table 58. North America Artesunate Drugs Revenue Market Share by Countries (2015-2020)
Table 59. Europe Artesunate Drugs Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Artesunate Drugs Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Artesunate Drugs Revenue by Countries (2015-2020)
Table 62. South America Artesunate Drugs Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Artesunate Drugs Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Artesunate Drugs Revenue Market Share by Countries (2015-2020)
Table 65. Global Artesunate Drugs Revenue (Million USD) by Type (2015-2020)
Table 66. Global Artesunate Drugs Revenue Share by Type (2015-2020)
Table 67. Global Artesunate Drugs Revenue Forecast by Type (2021-2025)
Table 68. Global Artesunate Drugs Revenue by Application (2015-2020)
Table 69. Global Artesunate Drugs Revenue Share by Application (2015-2020)
Table 70. Global Artesunate Drugs Revenue Forecast by Application (2021-2025)
Table 71. Global Artesunate Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Artesunate Drugs Picture
Figure 2. Global Artesunate Drugs Revenue Market Share by Type in 2019
Figure 3. Monoaromatic Artesunate Picture
Figure 4. Compound Artesunate Picture
Figure 5. Artesunate Drugs Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Other Picture
Figure 9. Global Artesunate Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Artesunate Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Artesunate Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Artesunate Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Artesunate Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Artesunate Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Artesunate Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Artesunate Drugs Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Artesunate Drugs Revenue Market Share in 2019
Figure 18. Global Top 10 Players Artesunate Drugs Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Artesunate Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Artesunate Drugs Revenue Market Share by Regions (2015-2020)
Figure 22. Global Artesunate Drugs Revenue Market Share by Regions in 2018
Figure 23. North America Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 24. Europe Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 26. South America Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 28. North America Artesunate Drugs Revenue Market Share by Countries (2015-2020)
Figure 29. North America Artesunate Drugs Revenue Market Share by Countries in 2019
Figure 30. USA Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Canada Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Europe Artesunate Drugs Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Artesunate Drugs Revenue Market Share by Countries in 2019
Figure 35. Germany Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 36. UK Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 37. France Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Russia Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Italy Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Artesunate Drugs Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Artesunate Drugs Revenue Market Share by Countries in 2019
Figure 42. China Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Japan Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Korea Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 45. India Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 47. South America Artesunate Drugs Revenue Market Share by Countries (2015-2020)
Figure 48. South America Artesunate Drugs Revenue Market Share by Countries in 2019
Figure 49. Brazil Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Artesunate Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Artesunate Drugs Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 54. UAE Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Artesunate Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Global Artesunate Drugs Revenue Share by Type (2015-2020)
Figure 58. Global Artesunate Drugs Revenue Share by Type in 2019
Figure 59. Global Artesunate Drugs Market Share Forecast by Type (2021-2025)
Figure 60. Global Monoaromatic Artesunate Revenue Growth Rate (2015-2020)
Figure 61. Global Compound Artesunate Revenue Growth Rate (2015-2020)
Figure 62. Global Artesunate Drugs Revenue Share by Application (2015-2020)
Figure 63. Global Artesunate Drugs Revenue Share by Application in 2019
Figure 64. Global Artesunate Drugs Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Clinic Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Artesunate Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Artesunate Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Artesunate Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Artesunate Drugs Revenue Market Forecast (2021-2025)
Figure 72. Europe Artesunate Drugs Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Artesunate Drugs Revenue Market Forecast (2021-2025)
Figure 74. South America Artesunate Drugs Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Artesunate Drugs Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel